Commentary/Editorials

Section Edited by Christian M. Capitini, MD Reaction to and/or perspectives on significant events in the field of cancer immunotherapy as pertains to basic science. May address a critical challenge; elaborate on, or extend a conversation of, a focal article; provide an application of a hypothetical perspective; or provide expert insight on a particular controversy in the field.